Investigation of the antifungal activity of carvacrol against strains of Cryptococcus neoformans

References

• Bakkali F, Averbeck S, Averbeck D, Idaomar M. 2008. Biological effects of essential oils – a review. Food Chem Toxicol. 46:446–475.
   PubMed Web of Science ®Google Scholar
• Bezerra LMD, Ferreira GLS, Silva ICG, Castro RD. 2013. Atividade antibacteriana in vitro de fitoconstituintes sobre micorganismos do biofilme dentário. Revista Brasileira De Ciências Da Saúde. 17:79–84.
   Google Scholar
• Bolard J, Joly V, Yeni P. 1993. Mechanism of action of amphotericin B at the cellular level. It's modulation by delivery system. J Liposome Res. 3:409–427.
   Google Scholar
• Cantón E, Pemán J, Viudes UM, Viudes A, Quindós G, Gobernado M, Espinel-Ingroff A. 2003. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn Microbiol Infect Dis. 45:203–206.
   PubMed Web of Science ®Google Scholar
• Carmo ES, Lima EO, Souza EL. 2008. The potential of Origanum vulgare L. (Lamiaceae) essential oil in inhibiting the growth of some food-related Aspergillus species. Braz J Microbiol. 39:362–367.
   PubMed Web of Science ®Google Scholar
• Carrillo-Muñoz AJ, Giusiano G, Ezkurra PA, Quindós G. 2006. Antifungal agents: mode of action in yeast cells. Rev Esp Quimioter. 19:130–139.
   PubMedGoogle Scholar
• Cavalcanti YM, Almeida LFD, Padilha WWN. 2001. Atividade antifúngica de três óleos essenciais sobre cepas de Candida. Revista Odontológica Do Brasil Central. 20:68–73.
   Google Scholar
• Chami N, Chami F, Bennis S, Troiillas J, Remmal A. 2004. A. Antifungal treatment witch carvacrol and eugenol of oral candidiasis in immunosuppressed rats. Braz J Infect Dis. 8:217–226.
   PubMedGoogle Scholar
• Chen SC, Sorrell TC. 2007. Antifungal agents. Med J Aust. 187:404–409.
   PubMed Web of Science ®Google Scholar
• Cleeland R, Squires E. (1991). Evaluation of new antimicrobials “in vitro” and in experimental animal infections. In: Lorian V. M. D., editor. Antibiotics in laboratory medicine. 3rd ed. Baltimore: Williams & Wilkins. p. 739–788.
   Google Scholar
• Cleff MB, Meinerz AR, Sallis ES, Antunes TA, Mattei A, Rodrigues MR, Meireles MCA, Mello JRB. 2008. Toxicidade pré-clínica em doses repetidas do óleo essencial do Origanum vulgare L. (Óregano) em ratas wistar. Lat Am J Pharm. 27:704–709.
   Google Scholar
• CLSI 2002. Clinical and Laboratory Standards Institute, formely NCCLS (National Committee for Clinical Laboratory Standards), Method M27-A2, 2nd ed. Wayne Ed.; v. 22, p. 1–29.
   Google Scholar
• Contin JT, Quaresma GS, Silva EF, Linardi VR. 2011. Ocorrência de Cryptococcus neoformans em fezes de pombos na cidade de Caratinga, MG – Brasil. Revista Médica De Minas Gerais. 21:19–24.
   Google Scholar
• Costa EV, Texeira SD, Marques FA, Teixeira SD, Marques FA, Duarte MC, Delarmelina C, Pinheiro ML, Trigo JR, Sales MBG. 2008. Chemical composition and antimicrobial activity of the essential oils of the Amazon Guatteriopsis species. Phytochemistry. 69:1895–1899.
   PubMed Web of Science ®Google Scholar
• Dalazen D, Zanrosso D, Wanderley L, Silva NL, Fuentefria AM. 2011. Comparação do perfil de suscetibilidade entre isolados clínicos de Candida spp. orais e vulvovaginais no Sul do Brasil. J Bras Patol Med Lab. 47:33–38.
   Google Scholar
• Eloff JN. 1998. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Medica. 64:711–713.
   PubMed Web of Science ®Google Scholar
• Ernst EJ, Klepser ME, Ernst ME, Messer SA, Pfaller MA. 1999. In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods. Diagn Microbiol Infect Dis. 33:75–80.
   PubMed Web of Science ®Google Scholar
• Escalante A, Gattuso M, Pérez P, Zacchino S. 2008. Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. J Nat Prod. 71:1720–1725.
   PubMed Web of Science ®Google Scholar
• Farmacopea Ufficiale Della Republica Italiana. 1998. X Edizione. Roma: Instituto Poligrafico e Zecco dello Stato, V.I, p. 206–210.
   Google Scholar
• Freitas MA, Andrade JC, Guedes GMM, Tintino SR, Souza CES, Leite NF, Gondim CNFL, Morais-Braga MFB, Matias EFF, Coutinho HDM. 2013. Avaliação in vitro da atividade antimicrobiana do carvacrol através dos métodos de contato direto e gasoso. Biosci J. 29:781–786.
   Google Scholar
• Gill AO, Holley RA. 2006. Description of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei membranes by plants oil aromatics. Int J Food Microbiol. 108:1–9.
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Rice LB. 1999. Antifugal agents: mode of action, mechanisms of resistance and correlation of these mechanisms with bacterial resistence. Clin Microbiol Rev. 12:501–517.
   PubMed Web of Science ®Google Scholar
• Greco WR, Bravo G, Parsons JC. 1995. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev. 47:331–385.
   PubMed Web of Science ®Google Scholar
• Gray KC, Palacios DS, Dailey I, Endo MM, Uno BE, Wilcock BC, Burke MD. 2012. Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci USA 109:2234–2239.
   PubMed Web of Science ®Google Scholar
• Hadacek F, Greger H. 2000. Testing of antifungal natural products: methodologies, comparatibility of results and assay choice. Phytochem Anal. 11:137–147.
   Web of Science ®Google Scholar
• Hammer KA, Carson CF, Riley TV. 1999. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol. 86:985–990.
   PubMed Web of Science ®Google Scholar
• Hammer KA, Carson CF, Riley TV. 2004. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother. 53:1081–1085.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang Z, Han X, Tang J, Wang J, Dong S, Wang E. 2002. Ion channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy. Biophys J. 83:3245–3255.
   PubMed Web of Science ®Google Scholar
• Kaloustion J, Chevalier J, Mikail C, Martino M, Abou L, Vergenes MF. 2008. Étude de six huiles essentielles: composition chimique et activité antibactérienne. Phytotherapié. 6:160–164.
   Google Scholar
• Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. 1998. Influence of test conditions on antifungal time-kill curve results: proposal of standardized methods. Antimicrob Agents Chemother. 42:1207–1212.
   PubMed Web of Science ®Google Scholar
• Larabi M, Gulik A, Dedieu JP, Legrand P, Barratt G, Cheron M. 2004. New lipid formulation of amphotericin B: spectral and microscopic analysis. Biochimica et Biophysica Acta – Biomembranes. 1664:172–181.
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee JR, Lunde CS, Kubo I. 1999. In vitro antifungal susceptibilities of Candida albicans and other fungal pathogens to polygodial, a sesquiterpene dialdehyde. Planta Medica. 65:204–208.
   PubMed Web of Science ®Google Scholar
• Leo A, Hansh C, Jow PYC. 1976. Dependence of hydrophobicity of apolar molecules on their molecular volume. J Med Chem. 19:611–615.
   PubMed Web of Science ®Google Scholar
• Lima IO, Oliveira RAG, Lima EO. 2005. Inhibitory effect of some phytochemicals in the growth of yeasts potentially causing opportunistic infections. Revista Brasileira De Ciências Farmacêuticas. 41:199–203.
   Google Scholar
• Lima IO, Pereira FO, Oliveira WA. 2013. Antifungal activity and mode of action of carvacrol against Candida albicans strains. J Essent Oil Res. 25:138–142.
   Web of Science ®Google Scholar
• Lozano-Chiu M, Paetznick VL, Gannoum MA, Rex JH. 1998. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodology. J Clin Microbiol. 36:2817–2822.
   PubMed Web of Science ®Google Scholar
• Machado LC, Gnoatto SA, Kluppel MLW. 2007. Lipossomas aplicados em farmacologia. Estudos Biologia. 29:215–224.
   Google Scholar
• Manohar V, Ingram C, Gray J, Talpur NA, Echard BW, Bagchi D, Preuss HG. 2001. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem. 228:111–117.
   PubMed Web of Science ®Google Scholar
• Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J. 2002. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med. 347:2020–2029.
   PubMed Web of Science ®Google Scholar
• Moreira MEL. 2005. Controvérsias a respeito da sepse fúngica no pré-termo extremo: profilaxia e esquemas terapêuticos. Jornal Pediatria. 81:S52–S57.
   PubMedGoogle Scholar
• Nguyen MH, Yu CY. 1998. In vitro comparative efficacy of vorconazole nd itrconzole against fluconazole-susceptible and resistant Cryptococcus neoformans isolates. Antimicrob Agents Chemother. 42:471–472.
   PubMed Web of Science ®Google Scholar
• Nobre MO, Nascente PS, Meireles MC, Ferreiro L. 2002. Drogas antifúngicas para pequenos e grandes animais. Ciência Rural. 32:175–184.
   Google Scholar
• Odds FC. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 52:1
   PubMed Web of Science ®Google Scholar
• Park BJ, Wannemuehler KA, Marston BJ. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 23:525–530.
   PubMed Web of Science ®Google Scholar
• Pozzatti P, Muller LG, Spader TB, Alves SH. 2006. Atividade antimicrobiana de óleos essenciais extraídos de condimentos. Revista Saúde. 32:53–58.
   Google Scholar
• Pozzatti P, Loreto ES, Lopes PG, Athayde ML, Santurio JM, Alves SH. 2010. Comparison of the susceptibilities of clinical isolates of Candida albicans and Candida dubliniensis to essential oils. Mycoses. 53:12–15.
   PubMed Web of Science ®Google Scholar
• Queiroz PJAF, Sousa FDN, Lage RA, Izael MA, Santos AG. 2008. Criptococose – Uma revisão bibliográfica. Acta Veterinária Brasílica. 2:32–38.
   Google Scholar
• Rios JL, Recio MC. 2005. Medicinal plants and antimicrobial activity. J Ethnopharmacol. 100:80–84.
   PubMed Web of Science ®Google Scholar
• Rosato A, Vitali C, Gallo D, Ballenzano L, Malamaci R. 2008. The inhibition of Candida species by selected essential oils and their synergism with amphotericin B. Phytomedicine. 15:635–638.
   PubMed Web of Science ®Google Scholar
• Sara R, Takahashi K, Branch RA, Badr KF. 1990. Mechanisms of amphotericin B-induced reduction of the glomerular filtration rate: a micropuncture study . J Pharmacol Exp Ther. 253:34–37.
   PubMed Web of Science ®Google Scholar
• Sikkema J, Bont JAM, Poolman B. 1995. Mechanisms of Membrane Toxicity of Hydrocarbons. Microbiol Rev. 59:201–222.
   PubMedGoogle Scholar
• Thevissen K, Kathelijne KA, Ferket I, Ferket KK, François IE, Camue BP. 2003. Interactions of antifungal plant defensins with fungal membrane components. Peptides. 24:1705–1712.
   PubMed Web of Science ®Google Scholar
• Ultee A, Bennik MHJ, Moezelaar R. 2002. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl Environ Microb. 68:1561–1568.
   PubMed Web of Science ®Google Scholar
• Wright JS, Shadnia H. 2008. Computational modeling of substituent effects on phenol toxicity. Chem Res Toxicol. 21:1426–1432.
   PubMed Web of Science ®Google Scholar
• Zacchino S. (2001). Estratégias para a descoberta de novos agentes antifúngicos. In: Yunes RA, Calixto JB, editors. Plantas medicinais sob a ótica da moderna química medicinal. Chapecó: Argos. p. 435–479.
   Google Scholar